Lost Money on Integra LifeSciences Holdings Corporation Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 21.2% Stock Decline
LOS ANGELES--( BUSINESS WIRE)--Integra LifeSciences Holdings Corporation ("Integra" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Integra LifeSciences Holdings Corporation (NASDAQ: IART), examining whether the Company may have violated the federal securities laws. The investigation centers on the disclosure about Integra LifeSciences Holdings Corporation on October 2, 2026.
If you lost money on Integra LifeSciences Holdings Corporation securities, share your Integra LifeSciences Holdings Corporation loss information with the firm to learn about potentially pursuing a claim to recover your losses.
Integra LifeSciences Holdings Corporation investigation at a glance
What happened?
On October 2, 2026, Integra announced updated full year guidance and preliminary third quarter results. The Company disclosed, among other things, that due to a July flood at its Cincinnati manufacturing facility, “disruption negatively impacted third quarter revenue by approximately $7 million and is expected to negatively impact fourth quarter revenue by approximately $15 million to $20 million.” Integra also slashed its 2026 revenue guidance by approximately $30.5 million at the midpoint.
On this news, Integra shares fell $3.41 or 21.2%, closing at $12.68 on October 2, 2026, thereby injuring investors.
Then, on October 21, 2026, Integra reported final third quarter results. Among other items, the Company disclosed “the Cincinnati disruption proved more significant than initially expected.” The Company announced it expected fourth quarter revenue of $413 million to $433 million (down 0.5% to 5.2%). The Company further disclosed “more measured expectations for portions of our Tissue Reconstruction business” in part because “growth in Tissue Reconstruction did not materialize as anticipated.”
On this news, Integra’s stock fell $1.49 or 11.18% to close at $11.84 on October 21, 2026, thereby injuring investors further.
"Integra LifeSciences Holdings Corporation shares dropped 21.2% after it was disclosed on October 2, 2026 that Integra had cut its 2026 revenue guidance by approximately $30.5 million at the midpoint and said a July flood at its Cincinnati manufacturing facility reduced third quarter revenue by about $7 million and would reduce fourth quarter revenue by $15 million to $20 million. Our investigation will look at whether investors had complete and accurate information before that disclosure," said Frank R. Cruz of The Law Offices of Frank R. Cruz.
What should Integra LifeSciences Holdings Corporation investors do now?
The Law Offices of Frank R. Cruz is investigating potential claims on behalf of Integra LifeSciences Holdings Corporation investors. Investors who lost money can visit the Integra LifeSciences Holdings Corporation investigation page, email info@frankcruzlaw.com, or call 310-914-5007.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
Questions and answers about the Integra LifeSciences Holdings Corporation investigation
Who is eligible? Investors who purchased Integra LifeSciences Holdings Corporation securities and suffered losses may have claims, and can contact the firm to find out whether the Integra LifeSciences Holdings Corporation investigation affects them.
What does a securities fraud investigation involve? In the Integra LifeSciences Holdings Corporation investigation, The Law Offices of Frank R. Cruz is examining whether the Company or its executives may have made false or misleading statements to investors in violation of the federal securities laws.
Is there a lawsuit? This release announces an investigation by The Law Offices of Frank R. Cruz, not a lawsuit. If a securities class action is later filed against Integra LifeSciences Holdings Corporation, investors may be able to seek appointment as lead plaintiff.
How are attorneys' fees handled? The Law Offices of Frank R. Cruz works on contingency, so Integra LifeSciences Holdings Corporation investors pay no attorneys' fees up front. Any attorneys' fees and litigation expenses come only from a recovery, if there is one, and require court approval.
Information for whistleblowers
Anyone with non-public information about Integra LifeSciences Holdings Corporation should consider their options to assist the investigation or participate in the SEC Whistleblower Program. The program allows whistleblowers who provide original information leading to a successful SEC enforcement action to receive awards of 10 to 30 percent of the sanctions collected, when those sanctions exceed $1 million. For more information, contact Frank R. Cruz at 310-914-5007 or email info@frankcruzlaw.com.
About The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz investigates and prosecutes securities fraud and corporate malfeasance class actions. With nearly 20 years of litigation experience, the firm focuses on complex securities class actions and gives each client personal, one-on-one attention throughout the legal process.
Prior results do not guarantee a similar outcome.
Related links
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.